Found: 12
Select item for more details and to access through your institution.
Heterologous vaccination against human tuberculosis modulates antigen-specific CD4<sup>+</sup> T-cell function.
- Published in:
- European Journal of Immunology, 2013, v. 43, n. 9, p. 2409, doi. 10.1002/eji.201343454
- By:
- Publication type:
- Article
Correction: Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4.
- Published in:
- European Journal of Immunology, 2011, v. 41, n. 5, p. 1501, doi. 10.1002/eji.201190030
- By:
- Publication type:
- Article
The Candidate TB Vaccine, MVA85A, Induces Highly Durable Th1 Responses.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0087340
- By:
- Publication type:
- Article
GEOENGINEERING: ISSUES OF ACCOUNTABILITY IN INTERNATIONAL LAW.
- Published in:
- Nevada Law Journal, 2015, v. 15, n. 2, p. 1060
- By:
- Publication type:
- Article
Longitudinal changes in CD4(+) T-cell memory responses induced by BCG vaccination of newborns.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Longitudinal Changes in CD4+ T-Cell Memory Responses Induced by BCG Vaccination of Newborns.
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 7, p. 1084, doi. 10.1093/infdis/jis941
- By:
- Publication type:
- Article
Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South Africa.
- Published in:
- Journal of Infectious Diseases, 2008, v. 198, n. 4, p. 544, doi. 10.1086/590185
- By:
- Publication type:
- Article
Best practices for user consultation in flow cytometry shared resource laboratories.
- Published in:
- Cytometry. Part A, 2024, v. 105, n. 9, p. 704, doi. 10.1002/cyto.a.24891
- By:
- Publication type:
- Article
Differential leukocyte counting and immunophenotyping in cryopreserved ex vivo whole blood.
- Published in:
- Cytometry. Part A, 2015, v. 87, n. 2, p. 157, doi. 10.1002/cyto.a.22610
- By:
- Publication type:
- Article
A Phase Ila Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected Adults.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2012, v. 185, n. 7, p. 769, doi. 10.1164/rccm.201108-1548oc
- By:
- Publication type:
- Article
Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4.
- Published in:
- European Journal of Immunology, 2010, v. 40, n. 1, p. 279, doi. 10.1002/eji.200939754
- By:
- Publication type:
- Article
Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population.
- Published in:
- PLoS ONE, 2017, v. 12, n. 9, p. 1, doi. 10.1371/journal.pone.0184563
- By:
- Publication type:
- Article